<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="1" humanitarian="0" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>SE-0-SE-29-2013-6174-285-13020</iati-identifier>
  <reporting-org ref="SE-0" secondary-reporter="0" type="10">
   <narrative xml:lang="EN">Sweden</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">SWE-2010-159 Prevention of unsafe abortion through increasing access to medical abortion and effective contraception</narrative>
   <narrative xml:lang="SV">SWE-2010-159 Prevention of unsafe abortion through increasing access to medical abortion and effective contraception</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">The project aims at preventing unsafe abortion through access to medical abortion and contraception. An intervention to provide &gt; 5000 women from &gt;100 countries lacking safe abortion services with medical abortion via telemedicine will be analysed. In an attempt to prevent horizontal transmission of HIV, condoms currently represent the only effective contraceptive method available. However, given the large number of HIV-infected children born annually, additional contraceptive methods for HIV-infected women are needed especially in countries were access to safe abortion is lacking. The levonorgestrel releasing intrauterine system will be investigated in a randomised controlled trial with regard to safety (viral load, CD4 cell levels, concentration of HIV viral copies in the cervical mucus), acceptability and prevalence of genital infection among HIV positive women in Uganda.</narrative>
   <narrative xml:lang="SV">The project aims at preventing unsafe abortion through access to medical abortion and contraception. An intervention to provide &gt; 5000 women from &gt;100 countries lacking safe abortion services with medical abortion via telemedicine will be analysed. In an attempt to prevent horizontal transmission of HIV, condoms currently represent the only effective contraceptive method available. However, given the large number of HIV-infected children born annually, additional contraceptive methods for HIV-infected women are needed especially in countries were access to safe abortion is lacking. The levonorgestrel releasing intrauterine system will be investigated in a randomised controlled trial with regard to safety (viral load, CD4 cell levels, concentration of HIV viral copies in the cervical mucus), acceptability and prevalence of genital infection among HIV positive women in Uganda.</narrative>
  </description>
  <participating-org ref="51000" role="4" type="80">
   <narrative xml:lang="EN">Karolinska Institutet</narrative>
  </participating-org>
  <participating-org ref="SE-0" role="1" type="10">
   <narrative xml:lang="EN">Sweden</narrative>
  </participating-org>
  <participating-org ref="SE-29" role="3" type="10">
   <narrative xml:lang="EN">The Swedish Research Council</narrative>
  </participating-org>
  <activity-status code="4"></activity-status>
  <activity-date iso-date="2011-01-01" type="1"></activity-date>
  <activity-date iso-date="2011-01-01" type="2"></activity-date>
  <activity-date iso-date="2013-12-31" type="3"></activity-date>
  <activity-date iso-date="2013-12-31" type="4"></activity-date>
  <contact-info>
   <organisation>
    <narrative xml:lang="EN">The Swedish Research Council</narrative>
   </organisation>
   <telephone>+46 8 546 44 000</telephone>
   <email>vetenskapsradet@vr.se</email>
   <website>www.vr.se</website>
   <mailing-address>
    <narrative xml:lang="EN">Box 1035, 101 38 Stockholm, Sweden</narrative>
   </mailing-address>
  </contact-info>
  <recipient-country code="UG" percentage="100">
   <narrative xml:lang="EN">Uganda</narrative>
  </recipient-country>
  <sector code="130" percentage="100" vocabulary="2">
   <narrative xml:lang="EN">Population Policies/Programmes &amp; Reproductive Health</narrative>
  </sector>
  <sector code="13020" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">Reproductive health care</narrative>
  </sector>
  <policy-marker code="5" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Convention on Biological Diversity</narrative>
  </policy-marker>
  <policy-marker code="8" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Convention to Combat Desertification</narrative>
  </policy-marker>
  <policy-marker code="7" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Framework Convention on Climate Change - Adaptation</narrative>
  </policy-marker>
  <policy-marker code="6" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Framework Convention on Climate Change - Mitigation</narrative>
  </policy-marker>
  <policy-marker code="2" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid to Environment</narrative>
  </policy-marker>
  <policy-marker code="11" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Disability</narrative>
  </policy-marker>
  <policy-marker code="10" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Disaster Risk Reduction(DRR)</narrative>
  </policy-marker>
  <policy-marker code="1" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Gender Equality</narrative>
  </policy-marker>
  <policy-marker code="3" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Participatory Development/Good Governance</narrative>
  </policy-marker>
  <policy-marker code="9" significance="2" vocabulary="1">
   <narrative xml:lang="EN">Reproductive, Maternal, Newborn and Child Health (RMNCH)</narrative>
  </policy-marker>
  <policy-marker code="4" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Trade Development</narrative>
  </policy-marker>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="D02" vocabulary="1"></default-aid-type>
  <default-tied-status code="4"></default-tied-status>
  <budget>
   <period-start iso-date="2013-01-01"></period-start>
   <period-end iso-date="2013-12-28"></period-end>
   <value currency="USD" value-date="2013-01-01">122827.4887919916</value>
  </budget>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2011-01-01"></transaction-date>
   <value currency="USD" value-date="2011-01-01">123281.7604635394</value>
  </transaction>
  <crs-add>
   <other-flags code="1" significance="1"></other-flags>
  </crs-add>
  <sida:contribution xmlns:sida="http://sida.se/ns/contribution#"></sida:contribution>
 </iati-activity>
</iati-activities>
